Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (16)

2022

  1. Campylobacter fetus meningitis and subdural empyema

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 4, pp. 212-213

  2. Clinical Features and Risk Factors for Mortality Among Long-term Care Facility Residents Hospitalized Due to COVID-19 in Spain

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 77, Núm. 4, pp. E138-E147

2021

  1. Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom

    Lupus, Vol. 30, Núm. 5, pp. 702-706

  2. Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers withdrawal is associated with higher mortality in hospitalized patients with covid‐19

    Journal of Clinical Medicine, Vol. 10, Núm. 12

  3. Campylobacter fetus meningitis and subdural empyema

    Enfermedades Infecciosas y Microbiologia Clinica

  4. Cardiometabolic therapy and mortality in very old patients with diabetes hospitalized due to COVID-19

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 76, Núm. 8, pp. E102-E109

  5. Clinical Characteristics and Risk Factors of Respiratory Failure in a Cohort of Young Patients Requiring Hospital Admission with SARS-CoV2 Infection in Spain: Results of the Multicenter SEMI-COVID-19 Registry

    Journal of General Internal Medicine, Vol. 36, Núm. 10, pp. 3080-3087

  6. Daptomycin associated eosinophilic pneumonia

    Medicina Clinica

  7. Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry

    Journal of General Internal Medicine, Vol. 36, Núm. 11, pp. 3478-3486

  8. Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain

    Hypertension, Vol. 77, Núm. 3, pp. 856-867

  9. The use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now?

    Expert Opinion on Biological Therapy, Vol. 21, Núm. 5, pp. 639-647

  10. Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study

    Revista Clinica Espanola, Vol. 221, Núm. 9, pp. 517-528